Cargando…

How to Best Protect People With Diabetes From the Impact of SARS-CoV-2: Report of the International COVID-19 and Diabetes Summit

The coronavirus disease 2019 (COVID-19) pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus has rapidly involved the entire world and exposed the pressing need for collaboration between public health and other stakeholders from the clinical, scientific, regulato...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Jennifer Y., Shang, Trisha, Ahn, David, Chen, Kong, Coté, Gerard, Espinoza, Juan, Mendez, Carlos E., Spanakis, Elias K., Thompson, Bithika, Wallia, Amisha, Wisk, Lauren E., Kerr, David, Klonoff, David C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7925443/
https://www.ncbi.nlm.nih.gov/pubmed/33476193
http://dx.doi.org/10.1177/1932296820978399
_version_ 1783659268473356288
author Zhang, Jennifer Y.
Shang, Trisha
Ahn, David
Chen, Kong
Coté, Gerard
Espinoza, Juan
Mendez, Carlos E.
Spanakis, Elias K.
Thompson, Bithika
Wallia, Amisha
Wisk, Lauren E.
Kerr, David
Klonoff, David C.
author_facet Zhang, Jennifer Y.
Shang, Trisha
Ahn, David
Chen, Kong
Coté, Gerard
Espinoza, Juan
Mendez, Carlos E.
Spanakis, Elias K.
Thompson, Bithika
Wallia, Amisha
Wisk, Lauren E.
Kerr, David
Klonoff, David C.
author_sort Zhang, Jennifer Y.
collection PubMed
description The coronavirus disease 2019 (COVID-19) pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus has rapidly involved the entire world and exposed the pressing need for collaboration between public health and other stakeholders from the clinical, scientific, regulatory, pharmaceutical, and medical device and technology communities. To discuss how to best protect people with diabetes from serious outcomes from COVID-19, Diabetes Technology Society, in collaboration with Sansum Diabetes Research Institute, hosted the “International COVID-19 and Diabetes Virtual Summit” on August 26-27, 2020. This unique, unprecedented real-time conference brought together physicians, scientists, government officials, regulatory experts, industry representatives, and people with diabetes from six continents to review and analyze relationships between COVID-19 and diabetes. Over 800 attendees logged in. The summit consisted of five sessions: (I) Keynotes, (II) Preparedness, (III) Response, (IV) Recovery, and (V) Surveillance; eight parts: (A) Background, (B) Resilience, (C) Outpatient Care, (D) Inpatient Care, (E) Resources, (F) High-Risk Groups, (G) Regulation, and (H) The Future; and 24 sections: (1) Historic Pandemics and Impact on Society, (2) Pathophysiology/Risk Factors for COVID-19, (3) Social Determinants of COVID-19, (4) Preparing for the Future, (5) Medications and Vaccines, (6) Psychology of Patients and Caregivers, (7) Outpatient Treatment of Diabetes Mellitus and Non-Pharmacologic Intervention, (8) Technology and Telehealth for Diabetes Outpatients, (9) Technology for Inpatients, (10) Management of Diabetes Inpatients with COVID-19, (11) Ethics, (12) Accuracy of Diagnostic Tests, (13) Children, (14) Pregnancy, (15) Economics of Care for COVID-19, (16) Role of Industry, (17) Protection of Healthcare Workers, (18) People with Diabetes, (19) International Responses to COVID-19, (20) Government Policy, (21) Regulation of Tests and Treatments, (22) Digital Health Technology, (23) Big Data Statistics, and 24) Patient Surveillance and Privacy. The two keynote speeches were entitled (1) COVID-19 and Diabetes—Meeting the Challenge and (2) Knowledge Gaps and Research Opportunities for Diabetes and COVID-19. While there was an emphasis on diabetes and its interactions with COVID-19, the panelists also discussed the COVID-19 pandemic in general. The meeting generated many novel ideas for collaboration between experts in medicine, science, government, and industry to develop new technologies and disease treatment paradigms to fight this global pandemic.
format Online
Article
Text
id pubmed-7925443
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-79254432021-03-18 How to Best Protect People With Diabetes From the Impact of SARS-CoV-2: Report of the International COVID-19 and Diabetes Summit Zhang, Jennifer Y. Shang, Trisha Ahn, David Chen, Kong Coté, Gerard Espinoza, Juan Mendez, Carlos E. Spanakis, Elias K. Thompson, Bithika Wallia, Amisha Wisk, Lauren E. Kerr, David Klonoff, David C. J Diabetes Sci Technol Proceedings of Meetings/Conferences The coronavirus disease 2019 (COVID-19) pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus has rapidly involved the entire world and exposed the pressing need for collaboration between public health and other stakeholders from the clinical, scientific, regulatory, pharmaceutical, and medical device and technology communities. To discuss how to best protect people with diabetes from serious outcomes from COVID-19, Diabetes Technology Society, in collaboration with Sansum Diabetes Research Institute, hosted the “International COVID-19 and Diabetes Virtual Summit” on August 26-27, 2020. This unique, unprecedented real-time conference brought together physicians, scientists, government officials, regulatory experts, industry representatives, and people with diabetes from six continents to review and analyze relationships between COVID-19 and diabetes. Over 800 attendees logged in. The summit consisted of five sessions: (I) Keynotes, (II) Preparedness, (III) Response, (IV) Recovery, and (V) Surveillance; eight parts: (A) Background, (B) Resilience, (C) Outpatient Care, (D) Inpatient Care, (E) Resources, (F) High-Risk Groups, (G) Regulation, and (H) The Future; and 24 sections: (1) Historic Pandemics and Impact on Society, (2) Pathophysiology/Risk Factors for COVID-19, (3) Social Determinants of COVID-19, (4) Preparing for the Future, (5) Medications and Vaccines, (6) Psychology of Patients and Caregivers, (7) Outpatient Treatment of Diabetes Mellitus and Non-Pharmacologic Intervention, (8) Technology and Telehealth for Diabetes Outpatients, (9) Technology for Inpatients, (10) Management of Diabetes Inpatients with COVID-19, (11) Ethics, (12) Accuracy of Diagnostic Tests, (13) Children, (14) Pregnancy, (15) Economics of Care for COVID-19, (16) Role of Industry, (17) Protection of Healthcare Workers, (18) People with Diabetes, (19) International Responses to COVID-19, (20) Government Policy, (21) Regulation of Tests and Treatments, (22) Digital Health Technology, (23) Big Data Statistics, and 24) Patient Surveillance and Privacy. The two keynote speeches were entitled (1) COVID-19 and Diabetes—Meeting the Challenge and (2) Knowledge Gaps and Research Opportunities for Diabetes and COVID-19. While there was an emphasis on diabetes and its interactions with COVID-19, the panelists also discussed the COVID-19 pandemic in general. The meeting generated many novel ideas for collaboration between experts in medicine, science, government, and industry to develop new technologies and disease treatment paradigms to fight this global pandemic. SAGE Publications 2021-01-21 /pmc/articles/PMC7925443/ /pubmed/33476193 http://dx.doi.org/10.1177/1932296820978399 Text en © 2021 Diabetes Technology Society https://creativecommons.org/licenses/by/4.0/This article is distributed under the terms of the Creative Commons Attribution 4.0 License (https://creativecommons.org/licenses/by/4.0/) which permits any use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Proceedings of Meetings/Conferences
Zhang, Jennifer Y.
Shang, Trisha
Ahn, David
Chen, Kong
Coté, Gerard
Espinoza, Juan
Mendez, Carlos E.
Spanakis, Elias K.
Thompson, Bithika
Wallia, Amisha
Wisk, Lauren E.
Kerr, David
Klonoff, David C.
How to Best Protect People With Diabetes From the Impact of SARS-CoV-2: Report of the International COVID-19 and Diabetes Summit
title How to Best Protect People With Diabetes From the Impact of SARS-CoV-2: Report of the International COVID-19 and Diabetes Summit
title_full How to Best Protect People With Diabetes From the Impact of SARS-CoV-2: Report of the International COVID-19 and Diabetes Summit
title_fullStr How to Best Protect People With Diabetes From the Impact of SARS-CoV-2: Report of the International COVID-19 and Diabetes Summit
title_full_unstemmed How to Best Protect People With Diabetes From the Impact of SARS-CoV-2: Report of the International COVID-19 and Diabetes Summit
title_short How to Best Protect People With Diabetes From the Impact of SARS-CoV-2: Report of the International COVID-19 and Diabetes Summit
title_sort how to best protect people with diabetes from the impact of sars-cov-2: report of the international covid-19 and diabetes summit
topic Proceedings of Meetings/Conferences
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7925443/
https://www.ncbi.nlm.nih.gov/pubmed/33476193
http://dx.doi.org/10.1177/1932296820978399
work_keys_str_mv AT zhangjennifery howtobestprotectpeoplewithdiabetesfromtheimpactofsarscov2reportoftheinternationalcovid19anddiabetessummit
AT shangtrisha howtobestprotectpeoplewithdiabetesfromtheimpactofsarscov2reportoftheinternationalcovid19anddiabetessummit
AT ahndavid howtobestprotectpeoplewithdiabetesfromtheimpactofsarscov2reportoftheinternationalcovid19anddiabetessummit
AT chenkong howtobestprotectpeoplewithdiabetesfromtheimpactofsarscov2reportoftheinternationalcovid19anddiabetessummit
AT cotegerard howtobestprotectpeoplewithdiabetesfromtheimpactofsarscov2reportoftheinternationalcovid19anddiabetessummit
AT espinozajuan howtobestprotectpeoplewithdiabetesfromtheimpactofsarscov2reportoftheinternationalcovid19anddiabetessummit
AT mendezcarlose howtobestprotectpeoplewithdiabetesfromtheimpactofsarscov2reportoftheinternationalcovid19anddiabetessummit
AT spanakiseliask howtobestprotectpeoplewithdiabetesfromtheimpactofsarscov2reportoftheinternationalcovid19anddiabetessummit
AT thompsonbithika howtobestprotectpeoplewithdiabetesfromtheimpactofsarscov2reportoftheinternationalcovid19anddiabetessummit
AT walliaamisha howtobestprotectpeoplewithdiabetesfromtheimpactofsarscov2reportoftheinternationalcovid19anddiabetessummit
AT wisklaurene howtobestprotectpeoplewithdiabetesfromtheimpactofsarscov2reportoftheinternationalcovid19anddiabetessummit
AT kerrdavid howtobestprotectpeoplewithdiabetesfromtheimpactofsarscov2reportoftheinternationalcovid19anddiabetessummit
AT klonoffdavidc howtobestprotectpeoplewithdiabetesfromtheimpactofsarscov2reportoftheinternationalcovid19anddiabetessummit